Investigation shows genetic barriers to plasma cell differentiation in IRF4 haploinsufficient mice, indicating unknown regulators like Junb.
Description High expression of the IRF4 transcription factor (TF) is required for upregulation of the Blimp-1 TF to commit an activated B cell toward the plasma cell (PC) fate. Our lab has shown in B cell-specific IRF4 haploinsufficient mice, not only is PC quantity expectedly diminished, but surprisingly, PC quality was impaired as well. Although these cells display the hallmarks of a functional PC, they fail to develop into complete PCs, suggesting there exists unknown genetic barriers to full PC development. We propose to use the IRF4 haploinsufficient model as a novel tool to investigate unknown genetic PC checkpoints. We hypothesize that dynamic accumulation of IRF4 fine-tunes the expression of agonistic and antagonistic PC regulators to dictate full PC differentiation and activity. We will collect genome-wide measurements of gene expression pattern, chromatin accessibilities, and IRF4 binding of wildtype and IRF4+/- PCs using RNA-, ATAC-, and ChIP-sequencing technologies. We will then integrate these datasets to establish a whole genome landscape of IRF4 activity and investigate differential patterns between wildtype and IRF4+/- PCs. Through differential analyses, we have identified several putative regulators including, Junb and miR-155, and continued investigation will enable us to determine direct or indirect IRF4 regulation. The goal of this study is to establish a more extensive gene regulatory network of PC differentiation and find yet-unknown barriers to PC differentiation. Funding Sources Supported by the Lodric Madox Fellowship, Topic Categories Lymphocyte Differentiation and Peripheral Maintenance (LYM)
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: